top of page

Treatment Developments

The Treatment of Hepatoblastoma: Its evolution and the current status as per SIOPEL trials

Pediatric Hepatoblastoma: diagnosis and treatment

Cisplatin vs. Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4) a prospective, single-arm, feasibility study

Redefining the Role of Doxorubicin for the Treatment of Children with Hepatoblastoma

Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children

Successful Treatment of Childhood High-Risk Hepatoblastoma with Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

Outcomes of pulmonary metastasis in hepatoblastoma - is the prognosis always poor?

Relapsed Hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy

Current and Future Management Strategies for Relapsed or Progressive Heptoblastoma

Relapse in hepatoblastoma patients: Clinical characteristics and outcome - Experience of the International Childhood Liver Tumor Strategy Group (SIOPEL)

Relapse & Metastasis

bottom of page